Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.
We have recently identified conventional B2 cells as atherogenic and B1a cells as atheroprotective in hypercholesterolemic ApoE(-/-) mice. Here, we examined the development of atherosclerosis in BAFF-R deficient ApoE(-/-) mice because B2 cells but not B1a cells are selectively depleted in BAFF-R def...
Guardado en:
Autores principales: | Tin Kyaw, Christopher Tay, Hamid Hosseini, Peter Kanellakis, Tahlia Gadowski, Fabeinne MacKay, Peter Tipping, Alex Bobik, Ban-Hock Toh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da712721b2494c80a384d6a1169e4e95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice
por: Pontus Dunér, et al.
Publicado: (2021) -
Testosterone is an endogenous regulator of BAFF and splenic B cell number
por: Anna S. Wilhelmson, et al.
Publicado: (2018) -
Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells
por: Padmapriya Ponnuswamy, et al.
Publicado: (2017) -
A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors
por: Michele Vigolo, et al.
Publicado: (2018) -
Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- mice.
por: Jianhui Zhuang, et al.
Publicado: (2013)